MCOLN1 and mucolipidosis type IV: Dermal fibroblasts from MLIV patients display decreased TRPML1 channel activity and impaired lysosome exocytosis as measured by the rate of NAG (N-acetyl-β-d-glucosaminidase) enzyme release following ionomycin treatment, effects which are rescued by TRPML1 overexpression [168].